Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions

Editorial

Peter D Siersema. Gastrointest Endosc. 2005 Oct.

. 2005 Oct;62(4):503-7.

doi: 10.1016/j.gie.2005.07.018.

No abstract available

Comment in

The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus.
van Veen RL, Robinson DJ, Siersema PD, Sterenborg HJ. van Veen RL, et al. Gastrointest Endosc. 2006 Nov;64(5):786-8. doi: 10.1016/j.gie.2006.06.056. Gastrointest Endosc. 2006. PMID: 17055875 No abstract available.

Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
Overholt BF, Lightdale CJ, Wang KK, Canto MI, Burdick S, Haggitt RC, Bronner MP, Taylor SL, Grace MG, Depot M; International Photodynamic Group for High-Grade Dysplasia in Barrett's Esophagus. Overholt BF, et al. Gastrointest Endosc. 2005 Oct;62(4):488-98. doi: 10.1016/j.gie.2005.06.047. Gastrointest Endosc. 2005. PMID: 16185958 Clinical Trial.
Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium.
Wolfsen HC. Wolfsen HC. Gastrointest Endosc. 2005 Oct;62(4):499-503. doi: 10.1016/j.gie.2005.07.017. Gastrointest Endosc. 2005. PMID: 16185960 No abstract available.